WASHINGTON, Feb. 20, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for ...

Insiders who bought US$126.0k worth of 60 Degrees Pharmaceuticals, Inc.'s (NASDAQ:SXTP) stock at an average buy price of US$1.27 over the last year may be disappointed by the recent 24% decrease ...

60 Degrees Pharmaceuticals (SXTP) announced the approval of an Investigational Review Board, IRB, sanctioned Phase II clinical study. The study will evaluate the efficacy and safety of the ARAKODA ...

Tonight: it will be quiet, mostly clear, and still cold. Lows will be in the upper teens to the middle 20s. Bundle up!

16:40 EST 60 Degrees Pharmaceuticals (SXTP) files to sell 3.74M shares of common stock for holder Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing ...

A powerful winter storm has slammed Norfolk, Virginia, shutting down major roadways and leaving drivers stranded in a sea of ...

Palm-cooling devices—designed to help humans bounce back quickly from exertion and heat stress by chilling their palms—are ...

The third winter storm that moved through central North Carolina on Wednesday, Feb. 19 brought everything from snow to sleet ...